Zoghbi Huda Y
SEC insider (Form 3/4/5 filer). CIK 0001681643. Director at REGENERON PHARMACEUTICALS, INC. (REGN). 16 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in TARRYTOWN, NY.
Companies Zoghbi Huda Y has filed insider reports for
- REGENERON PHARMACEUTICALS, INC. (REGN): Director
Zoghbi Huda Y
CIK: 0001681643
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENERON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 10, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect800 shares at avg. $800.00$640K - Aug 10, 2026REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect800 shares at avg. $376.69$301K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect49 shares at avg. $774.68$38K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect50 shares at avg. $775.50$39K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect53 shares at avg. $778.47$41K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect208 shares at avg. $779.55$162K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect331 shares at avg. $780.45$258K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect209 shares at avg. $781.28$163K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect298 shares at avg. $782.10$233K - Feb 19, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect220 shares at avg. $783.29$172K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 800 | $800.00 | $640,000 | Direct |
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 800 | $376.69 | $301,352 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 49 | $774.68 | $37,959 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 50 | $775.50 | $38,775 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 53 | $778.47 | $41,259 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 208 | $779.55 | $162,146 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 331 | $780.45 | $258,329 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 209 | $781.28 | $163,288 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 298 | $782.10 | $233,066 | Direct |
| Feb 19, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 220 | $783.29 | $172,324 | Direct |
1-10 of 16 transactions